152 related articles for article (PubMed ID: 31117081)
41. [A preliminary study of chemo-interferon therapy in malignant lymphoma].
Takeyama H; Yano K; Fukutani H; Watanabe E
Gan To Kagaku Ryoho; 1987 Jan; 14(1):140-5. PubMed ID: 3800402
[TBL] [Abstract][Full Text] [Related]
42. Fertility preservation after chemotherapy for Hodgkin lymphoma.
van der Kaaij MA; van Echten-Arends J; Simons AH; Kluin-Nelemans HC
Hematol Oncol; 2010 Dec; 28(4):168-79. PubMed ID: 20232475
[TBL] [Abstract][Full Text] [Related]
43. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
[TBL] [Abstract][Full Text] [Related]
44. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Demirer T; Weaver CH; Buckner CD; Petersen FB; Bensinger WI; Sanders J; Clift RA; Lilleby K; Anasetti C; Martin P
J Clin Oncol; 1995 Mar; 13(3):596-602. PubMed ID: 7884421
[TBL] [Abstract][Full Text] [Related]
45. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
46. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
47. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
48. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Ortin TT; Shostak CA; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):873-80. PubMed ID: 2211255
[TBL] [Abstract][Full Text] [Related]
49. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
Tessoulin B; Thomare P; Delande E; Moynard J; Gastinne T; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Boudreault JS; Perrin F; Lok A; Guillaume T; Garnier A; Peterlin P; Gallas P; Chevallier P; Moreau P; Le Gouill S
Ann Hematol; 2017 Jun; 96(6):943-950. PubMed ID: 28374163
[TBL] [Abstract][Full Text] [Related]
50. Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
Radford JA; Clark S; Crowther D; Shalet SM
Br J Cancer; 1994 Feb; 69(2):379-81. PubMed ID: 7507693
[TBL] [Abstract][Full Text] [Related]
51. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.
Kobrinsky NL; Sposto R; Shah NR; Anderson JR; DeLaat C; Morse M; Warkentin P; Gilchrist GS; Cohen MD; Shina D; Meadows AT
J Clin Oncol; 2001 May; 19(9):2390-6. PubMed ID: 11331317
[TBL] [Abstract][Full Text] [Related]
53. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
54. GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.
Valsamakis G; Valtetsiotis K; Charmandari E; Lambrinoudaki I; Vlahos NF
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216409
[TBL] [Abstract][Full Text] [Related]
55. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
56. Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network.
Martinez G; Walschaerts M; Le Mitouard M; Borye R; Thomas C; Auger J; Berthaut I; Brugnon F; Daudin M; Moinard N; Ravel C; Saias J; Szerman E; Rives N; Hennebicq S; Bujan L
Fertil Steril; 2017 Feb; 107(2):341-350.e5. PubMed ID: 27810161
[TBL] [Abstract][Full Text] [Related]
57. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Blumenfeld Z; von Wolff M
Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
[TBL] [Abstract][Full Text] [Related]
58. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
59. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
60. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
